A Quality Initiative Reducing Adverse Outcomes in Pediatric Patients with DKA During Intrafacility Transit

Michael J Stoner1,2, Kelli S Burkey2, Daniel M Cohen1,2

  • 1Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio.

Insights

This quality improvement project enhanced blood glucose monitoring for children with diabetic ketoacidosis (DKA) in the emergency department (ED). Utilizing electronic health records, monitoring compliance increased to over 90%, preventing hypoglycemia.

Area of Science:

  • Pediatric Endocrinology
  • Quality Improvement Science
  • Health Informatics

Background:

  • Diabetic ketoacidosis (DKA) treatment necessitates vigilant blood glucose monitoring to avert severe complications.
  • This project focused on optimizing blood glucose assessment timeliness for pediatric DKA patients during emergency department (ED) to inpatient unit transitions.
  • The initiative aimed to enhance the frequency of blood glucose checks within 30 minutes prior to transfer for children receiving insulin therapy.

Purpose of the Study:

  • To improve the rate of blood glucose monitoring within 30 minutes before transitioning pediatric patients with DKA from the ED to an inpatient setting.
  • To reduce the incidence of hypoglycemia in pediatric DKA patients undergoing continuous insulin infusion.

Main Methods:

  • A multidisciplinary team implemented a series of Plan-Do-Study-Act (PDSA) quality improvement cycles.
  • The electronic health record (EHR) system was leveraged to create prompts and direct clinical staff for timely blood glucose monitoring.
  • Key performance indicators included the percentage of patients with blood glucose levels checked within 30 minutes of ED departure and the occurrence of hypoglycemia.

Main Results:

  • From March 2015 to November 2017, 640 pediatric DKA patients were managed in the ED, with 629 admitted for continuous insulin infusion.
  • Blood glucose monitoring compliance within 30 minutes of transition increased from 56% to over 90% following PDSA cycle implementation.
  • No hypoglycemia events were reported after the final PDSA cycle was implemented.

Conclusions:

  • Leveraging EHR functionalities significantly improved adherence to International Society for Pediatric and Adolescent Diabetes guidelines for blood glucose monitoring during care transitions.
  • The implemented system demonstrated rapid, sustained improvements in monitoring compliance.
  • This quality improvement initiative is considered easily replicable, cost-effective, and enhances patient safety.
Abstract

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
264
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
238
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219